FEMY — FEMASYS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1339005 ·
Last close
$1.12
Market Cap
$9.38M
52W High
$20.80
52W Low
$1.07
ADV30
101,465
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 404,597 | 217,101 | -4,450,010 | -4,564,815 | 35,087,658 | 23,913,946 | 8,059,496 |
| Jun 2026 | 331,827 | 189,391 | -5,065,874 | -4,469,095 | 12,289,582 | 1,443,502 | 8,258,635 |
| Mar 2026 | 424,889 | 266,283 | -4,223,533 | 846,100 | 16,495,245 | 5,386,041 | 9,205,352 |
| Dec 2025 | 813,387 | 510,262 | -4,622,728 | -3,950,305 | 20,724,177 | 9,266,353 | 14,854,875 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-17,651,812
Investing CF
$-537,848
Financing CF
$16,415,095
CapEx
$-537,848
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.53
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-149,449,139
Inventory
$6,191,277
Receivables
$151,049
ST Investments
—
EBIT TTM
$-10,458,944
Pretax Income TTM
$-11,761,771
Interest Exp TTM
$1,302,827
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,299,497
EBITDA
$-17,229,926
Free Cash Flow
$-11,230,021
Enterprise Value
$15,239,281
Total Cash
$1,443,502
Total Debt
$4,790,245
Shares Out
8,375,027
Trailing EPS
$-3.28
Book Value
$1.97
ROE
-425.0%
ROA
-84.2%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,293,313 | -17,588,669 | -18,627,887 | 20,724,177 | 14,854,875 | 5,869,302 | -18,690,565 |
| Dec 2024 | 1,629,108 | -17,785,805 | -18,816,628 | 12,445,002 | 10,140,580 | 2,304,422 | -19,444,009 |
| Dec 2023 | 1,071,970 | -14,508,415 | -14,247,124 | 27,755,825 | 9,403,236 | 18,352,589 | -11,280,546 |
| Dec 2022 | 1,206,218 | -11,600,264 | -11,394,170 | 16,895,570 | 1,653,051 | 15,242,519 | -10,731,973 |
TTM Snapshot
Revenues TTM
$2,299,497
NetIncome TTM
$-11,768,121
OpCashFlow TTM
—
Assets (Latest)
$12,289,582
Forward EPS
$-2.12
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SINT | Sintx Technologies, Inc. | $9.22M | $1.22 | — |
| LFWD | Lifeward Ltd. | $8.80M | $3.10 | — |
| PLSM | Pulsenmore Ltd. | $8.78M | $1.35 | — |
| RGNT | REGENTIS BIOMATERIALS LTD. | $8.57M | $1.22 | — |
| ALRTF | ALR Technologies SG Ltd. | $10.46M | $0.02 | — |
News headlines (Yahoo Finance, 1h cache)
Femasys Announces Financial Results for Quarter Ended September 30, 2026 and Provides Corporate Update
2026-11-13 21:05 · Yahoo
Femasys Appoints John Moorhead to Board of Directors
2026-10-30 13:00 · Yahoo
Femasys Partners with SandsRx Pharmacy to Support FemaSeed® Fertility Portfolio Launch to OB/GYNs
2026-10-20 13:00 · Yahoo
Femasys Doubles Enrolling Sites in FemBloc FINALE Pivotal Trial for Non-Surgical Permanent Birth Control
2026-10-14 13:00 · Yahoo
Femasys to Showcase FemaSeed Fertility Treatment at ASRM 2026 as Commercialization Strategy Expands
2026-10-08 14:38 · Yahoo
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
2026-10-08 13:00 · Yahoo
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
2026-09-15 13:00 · Yahoo
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
2026-08-26 13:00 · Yahoo
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
2026-08-19 17:36 · Yahoo
FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential
2026-08-19 16:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.